Literatur
- 1
Collins R, Peto R, MacMahon S. et al .
Blood pressure, stroke and coronary heart disease. Part 2, Short-term reductions in
blood pressure: overview of randomised drug trials in their epidemiological context.
Lancet.
1990;
335
827-838
- 2
The ALLHAT Officers and Coordinators for the ALLHAT collaborative research group major
outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme
inhibitor or calcium channel blocker vs diuretic .
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
JAMA.
2002;
288
2981-2997
- 3
Verdecchia P, Reboldi G, Angeli F. et al .
Adverse prognostic significance of new diabetes in treated hypertensive subjects.
Hypertension.
2004;
43
963-969
- 4
Wing L MH, Reid C M, Ryan P. et al .
A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics
for hypertension in the elderly.
NEJM.
2003;
348
583-592
- 5
Dahlöf B, Devereux R B, Kjeldsen S E. et al .
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction
in hypertension study (LIFE): a randomised trial against atenolol.
Lancet.
2002;
359
995-1003
- 6
Carlberg B, Samuelsson O, Lindholm L H.
Atenolol in hypertension: is it a wise choice?.
Lancet.
2004;
364
1684-1689
- 7
Julius S, Kjeldsen S E, Weber M. et al. for the VALUE trial group .
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens
based on valsartan or amlodipine: the VALUE randomised trial.
Lancet.
2004;
363
2022-2031
- 8
Alberts M J.
Diagnosis and treatment of ischemic stroke.
Am J Med.
1999;
106
211-221
- 9
Eames P J, Blake M J, Dawson S L. et al .
Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired
in acute ischaemic stroke.
J Neurol Neurosurg Psychiatry.
2002;
72
467-472
- 10 Hacke W, Bode C, Busse O. et al .Ischämischer Schlaganfall: Akuttherapie. 3. Auflage
Thieme Verlag In: Diener HC (Hrsg.). Leitlinien für Diagnostik und Therapie in der
Neurologie 2005
- 11
PROGRESS Collaborative Group .
Randomised trial of a perindopril-based blood-presure lowering regimen among 6,105
individuals with previous stroke or transient ischaemic attack.
Lancet.
2001;
358
1033-1041
- 12
Staessen J A, Fagard R, Thijs L. et al. for the Systolic Hypertension in Europe (Syst-Eur)
Trial Investigators .
Randomised double-blind comparison of placebo and active treatment for older patients
with isolated systolic hypertension.
Lancet.
1997;
350
757-764
- 13
Schrader J, Lüders S, Kulschewski A. et al .
Morbidity and mortality after stroke, Eprosartan compared with Nitrendipine for secondary
prevention: Principal results of a prospective randomised controlled study (MOSES).
Stroke.
2005;
36
1218-1224
- 14 Leitlinien der Hochdruckliga 2005. unter: http://www.paritaet.org/RR-Liga/Hypertonie-Leitlinien05.pdf
- 15 http://www.sps3.org/ (Datum der Einsichtnahme: 14.10.2006)
- 16
Lithell H, Hansson L, Skoog I. et al .
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of
a randomized double-blind intervention trial.
J Hypertens.
2003;
21
875-886
- 17
Bulpitt C, Fletcher A, Beckett N. et al .
Hypertension in the very elderly trial (HYVET): protocol for the main trial.
Drugs Aging.
2001;
18
151-164
- 18
Rothwell P M, Howard S C, Spence J D.
Relationship between blood pressure and stroke risk in patients with symptomatic carotid
occlusive disease.
Stroke.
2003;
34
2583-2590
- 19
Sacco R L, Adams R, Albers G. et al .
Guidelines for prevention of stroke in patients with ischemic stroke or transient
ischemic attack: a statement for healthcare professionals from the American Heart
Association/American Stroke Association Council on Stroke: co-sponsored by the Council
on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms
the value of this guideline.
Stroke.
2006;
37
577-617
- 20
Arima H, Chalmers J, Woodward M. et al .
Lower target blood pressures are safe and effective for the prevention of recurrent
stroke: the PROGRESS trial.
J Hypertens.
2006;
24
1201-1208
Prof. Dr. med. E. B. Ringelstein
Poliklinik für Neurologie, Universitätsklinikum Münster
Albert-Schweitzer-Straße 33
48149 Münster
